Latest News of RXRX
Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid
By Yahoo! Finance | 3 days ago
Broker Revenue Forecasts For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Are Surging Higher
By Yahoo! Finance | 2 weeks ago
Morgan Stanley Assumes Coverage of Recursion Pharmaceuticals (RXRX) Stock with an Equal Weight Rating
By Yahoo! Finance | 1 month ago
Morgan Stanley Trims Recursion (RXRX) Price Target, Maintains Equal Weight Rating
By Yahoo! Finance | 1 month ago